Over 970 Oklahoma Auctions End Tomorrow 09/29 - Bid Now
Over 1300 Total Lots Up For Auction at Three Locations - NJ Cleansweep 09/30, CA 10/01, NJ 10/05

ASTRO 2013年: 对皮肤癌治疗的一种新的方法

Nancy Ryerson, Staff Writer | September 25, 2013
The Skin eBx from iCad.
Skin cancer is the most common cancer in the United States. Treatment of non-melanoma skin cancer, generally skin-marring surgery, increased by almost 77 percent between 1992 and 2006. Now, several radiation therapy manufacturers are offering a non-surgical option for treating skin cancer without leaving a scar.

"My co-worker has 21 scars on her arm, and she's only 32," said Michelle Joiner, director of Global PR and brand management at Elekta. At ASTRO, the company showed a new electronic brachytherapy solution called Esteya designed for treating non-melanoma skin cancer. Besides its cosmetic benefits, the method is also effective for areas that are hard to reach surgically, such as the top of the head.

At first, Elekta plans to market the system to radiation oncologists, but the company hopes to eventually introduce it to dermatologists as well. It's currently pending 510k approval.

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs

The brachytherapy company iCad has already found that dermatologists are now working with oncologists to treat skin cancer. The company showed its new brachytherapy treatment for non-melanoma skin cancer, Skin eBx, at ASTRO.

"Dermatologists can offer it in-office," said Stacey Stevens, senior vice president of marketing and strategy at iCad. "We've also seen more collaboration between oncologists and dermatologists."

The treatment is also a good option for international health care providers. Because it's portable and does not require a shielded room, smaller providers can treat patients with radiation without making a large investment.

Varian also reported an increased interest in brachytherapy for non-melanoma skin cancer, noting that it's a way customers can use equipment they already own in additional ways.

On the financial side, all three companies reported that at least a temporary reimbursement code is in place for radiation oncology for skin cancer, making it similar in price to high-end surgery.

You Must Be Logged In To Post A Comment